Grindeks is the Baltic leader pharmaceutical group. Net sales break down by activity as follows:
- research, development and manufacturing of pharmaceuticals (94.9%): medicines for the treatment of cardiovascular diseases, cancers and central nervous system disorders, analgesic products, treatments of cough and flu, etc.;
- production of pharmaceutical active ingredients (5.1%).
Net sales break down geographically as follows: Latvia (6.6%), Russia (59.6%), Lithuania (4%), Estonia (1.7%) and other (28.1%).
More about the company